COVID-19 Vaccination Breakthrough Infections in a Real-World Setting: Using Community Reporters to Evaluate Vaccine Effectiveness.

Reynolds, Matthew W; Xie, Yiqiong; Knuth, Kendall B; Mack, Christina D; Brinkley, Emma; Toovey, Stephen; Dreyer, Nancy A

Reynolds, Matthew W; Xie, Yiqiong; Knuth, Kendall B; Mack, Christina D; Brinkley, Emma; Toovey, Stephen; Dreyer, Nancy A.

Afiliação

Reynolds MW; Real World Solutions, IQVIA, Cambridge, MA, USA.
Xie Y; Real World Solutions, IQVIA, Cambridge, MA, USA.
Knuth KB; Real World Solutions, IQVIA, Cambridge, MA, USA.
Mack CD; Real World Solutions, IQVIA, Cambridge, MA, USA.
Brinkley E; Real World Solutions, IQVIA, Cambridge, MA, USA.
Toovey S; Virology, Pegasus Research, London, UK.
Dreyer NA; Real World Solutions, IQVIA, Cambridge, MA, USA.

Infect Drug Resist ; 15: 5167-5182, 2022.

Article em En | MEDLINE | ID: mdl-36090603

Palavras-chave

COVID-19; SARS-CoV-2; breakthrough infections; patient-reported outcomes; symptoms; vaccines

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Infect Drug Resist Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google